Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Palliative therapy.

Marjolein Y V Homs1, Ernst J Kuipers, Peter D Siersema

  • 1Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands.

Journal of Surgical Oncology
|November 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How to Manage a Patient With Gastric Intestinal Metaplasia: An International Perspective.

Gastroenterology·2020
Same author

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.

International journal of cancer·2019
Same author

Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.

The Journal of pathology·2019
Same author

Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group.

Annals of internal medicine·2019
Same author

Personalised screening for colorectal cancer, ready for take-off.

Gut·2019
Same author

Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study.

BMJ open·2019
Same journal

Institutional Learning Curve in Esophagectomy: Technical Standardization of Gastric Conduit Formation and Conduit-Related Outcomes in 187 Consecutive Patients.

Journal of surgical oncology·2026
Same journal

Evaluating the Accuracy of ChatGPT-4o in Addressing Complex Clinical Questions Based on NCCN Guidelines for Rectal Adenocarcinoma.

Journal of surgical oncology·2026
Same journal

Racial Differences in Breast Cancer Treatment and Information Access.

Journal of surgical oncology·2026
Same journal

Comparative Analysis of CEM and Breast MRI: A Retrospective Study.

Journal of surgical oncology·2026
Same journal

The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

Journal of surgical oncology·2026
Same journal

"It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

Journal of surgical oncology·2026
See all related articles

Palliative treatments for esophageal cancer aim to maintain oral intake and improve quality of life. Brachytherapy and chemotherapy show promise, with a multimodal approach potentially offering the best outcomes.

Area of Science:

  • Oncology
  • Gastroenterology
  • Palliative Care

Background:

  • Esophageal cancer significantly impacts quality of life, primarily through dysphagia.
  • Maintaining oral food intake is crucial for patient well-being.

Purpose of the Study:

  • To review and compare various palliative treatment options for esophageal cancer.
  • To assess the effectiveness and safety of different interventions for malignant dysphagia.

Main Methods:

  • Review of current treatment modalities including stent placement, photodynamic therapy, Nd:YAG laser, brachytherapy, and palliative chemotherapy.
  • Evaluation of treatment outcomes such as dysphagia relief, complication rates, and quality of life measures (EORTC QLQ-C30, EORTC-OES-18).

Main Results:

Related Experiment Videos

  • Stent placement provides rapid dysphagia relief but has high complication and recurrence rates.
  • Brachytherapy (12-16 Gy) demonstrates favorable long-term effectiveness and safety compared to stents.
  • Palliative chemotherapy shows response rates of 35-50%, with survival benefit yet to be established.

Conclusions:

  • Brachytherapy and potentially a combination of stent placement or brachytherapy with chemotherapy represent effective palliative strategies.
  • Quality of life measurement is essential for evaluating treatment efficacy in clinical trials.